高尔基体蛋白73与肝脏疾病的关系

魏丰贤; 刘钊; 耿婕; 苏国宏; 陈默; 王满才; 曹维嘉; 张有成

doi:10.3969/j.issn.1001-5256.2017.08.040

高尔基体蛋白73与肝脏疾病的关系

DOI: 10.3969/j.issn.1001-5256.2017.08.040

1. 兰州大学第二医院普外科
2. 兰州大学第一医院影像科
3. 普洱市人民医院普外烧伤整形外科

基金项目:

甘肃省消化系肿瘤重点实验室开放课题(lzujbky-2011-t03-04)；

详细信息

中图分类号: R575
计量
- 文章访问数: 2183
- HTML全文浏览量: 67
- PDF下载量: 388
- 被引次数: 0
出版历程
- 收稿日期: 2017-02-27
- 出版日期: 2017-08-20

Research advances in association between Golgi protein 73 and liver diseases

Department of General Surgery, Lanzhou University Second Hospital

Research funding:

摘要

摘要: 正常人体中高尔基体蛋白73(GP73)的表达水平很低,而在肝病及肝细胞癌患者中显著表达,因此其或可成为一种新型的肝细胞癌标志物。介绍了GP73在人体内的分布,初步划分了GP73的亚型,并依据不同亚型探讨了其与肝脏良恶性病变和相关外科手术的关系,以及GP73在良恶性病变鉴别中的应用现状。鉴于GP73与肝病的发生、发展和预后关系密切,故对最新的相关基础研究进展进行了归纳,阐述了岩藻糖基化GP73与肝癌细胞增殖、迁移和侵袭的结构基础及已发现的信号通路,并列举了其他可能影响GP73表达水平的因素。
- 高尔基体蛋白73 /
- 肝疾病 /
- 早期诊断 /
- 综述
Abstract: Golgi protein 73 ( GP73) has a very low expression level in normal people, while it has a significantly higher expression level in patients with liver diseases and hepatocellular carcinoma ( HCC) , and therefore, it may become a new marker for HCC. This article introduces the distribution of GP73 in human body and definitions of different subtypes of GP73 and elaborates on its association with benign/malignant liver diseases and surgical operation based on the subtypes of GP73, as well as the application of GP73 in the differentiation of benign/malignant liver diseases. Since GP73 is closely associated with the development, progression, and prognosis of liver diseases, this article summarizes the latest advances in basic research, introduces the structural basis of fucosylated GP73 and proliferation, migration, and invasion of hepatoma cells and known signaling pathways, and lists the factors which affect the expression of GP73.
- golgi protein 73 /
- liver diseases /
- early diagnosis /
- review

HTML全文

参考文献(28)

[1]GU JF, LI MF, GU SN.Research advances in the association between Golgi protein 73 and liver cancer[J].J Hepatopancreatobiliary Surg, 2011, 23 (6) :520-522. (in Chinese) 顾剑锋, 李明峰, 顾树南.GP73与肝癌关系的研究进展[J].肝胆胰外科杂志, 2011, 23 (6) :520-522.

[2]KLADNEY RD, BULLA GA, GUO L, et al.GP73, a novel Golgi-localized protein upregulated by viral infection[J].Gene, 2000, 249 (1-2) :53-65.

[3]KLADNEY RD, CUI X, BULLA GA, et al.Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease[J].Hepatology, 2002, 35 (6) :1431-1440.

[4]BACHERT C, FIMMEL C, LINSTEDT AD.Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma[J].Traffic, 2007, 8 (10) :1415-1423.

[5]IFTIKHAR R, KLADNEY RD, HAVLIOGLU N, et al.Diseaseand cell-specific expression of GP73 in human liver disease[J].Am J Gastroenterol, 2004, 99 (6) :1087-1095.

[6]RIENER MO, STENNER F, LIEWEN H, et al.Golgi phosphoprotein2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas[J].Hepatology, 2009, 49 (5) :1602-1609.

[7]SHAN SG, GAO YT, XU YJ, et al.Gradually increased Golgi protein 73 expression in the progression of benign liver diseases to precancerous lesions and hepatocellular carcinoma correlates with prognosis of patients[J].Hepatol Res, 2013, 43 (11) :1199-1210.

[8]GU Y, CHEN W, ZHAO Y, et al.Quantitative analysis of elevated serum Golgi protein-73 expression in patients with liver diseases[J].Ann Clin Biochem, 2009, 46 (Pt 1) :38-43.

[9]MAO Y, YANG H, XU H, et al.Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma[J].Gut, 2010, 59 (12) :1687-1693.

[10]XU Z, LIU L, PAN X, et al.Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease[J].Medicine (Baltimore) , 2015, 94 (12) :e659.

[11]SAI W, WANG L, ZHENG W, et al.Abnormal expression of Golgi protein 73 in clinical values and their role in HBV-related hepatocellular carcinoma diagnosis and prognosis[J].Hepat Mon, 2015, 15 (12) :e32918.

[12]MARRERO JA, ROMANO PR, NIKOLAEVA O, et al.GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma[J].J Hepatol, 2005, 43 (6) :1007-1012.

[13]DAI M, CHEN X, LIU X, et al.Diagnostic value of the combination of golgi protein 73 and alpha-fetoprotein in hepatocellular carcinoma:a meta-analysis[J].PLo S One, 2015, 10 (10) :e0140067.

[14]ZKAN H, ERDAL H, TUTKAK H, et al.Diagnostic and prognostic validity of Golgi protein 73 in hepatocellular carcinoma[J].Digestion, 2011, 83 (1-2) :83-88.

[15]LIU T, YAO M, LIU S, et al.Serum Golgi protein 73 is not a suitable diagnostic marker for hepatocellular carcinoma[J].Oncotarget, 2017, 8 (10) :16498-16506.

[16]PAN J, ZHANG YF, YANG HY, et al.The response of Golgi protein 73 to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma may relate to the influence of certain chemotherapeutics[J].Hepatobiliary Pancreat Dis Int, 2015, 14 (4) :406-412.

[17]CHEN JG, LU WZ, ZHU YR, et al.Retrospective observation of dynamic levels of serum Golgi protein 73 in patients prior to the onset of liver cancer[J].Chin J Prevent Med, 2013, 47 (8) :731-735. (in Chinese) 陈建国, 陆卫中, 朱源荣, 等.肝癌患者发病前血清中高尔基体糖蛋白73水平的回顾性动态观察[J].中华预防医学杂志, 2013, 47 (8) :731-735.

[18]ZHANG YL, ZHANG YC, HAN W, et al.Effect of GP73 silencing on proliferation and apoptosis in hepatocellular cancer[J].World J Gastroenterol, 2014, 20 (32) :11287-11296.

[19]CHEN M, ZHAO K, LIU PC, et al.Effects of silencing GP73 with siRNA interference on the migration and invasion of human hepatoma Hep G2 cells[J].J Shanghai Jiaotong Univ:Med Sci, 2016, 36 (11) :1588-1593. (in Chinese) 陈默, 赵坤, 柳鹏程, 等.RNA干扰技术沉默GP73对人肝癌Hep G2细胞迁移和侵袭的影响[J].上海交通大学学报:医学版, 2016, 36 (11) :1588-1593.

[20]JIN D, TAO J, LI D, et al.Golgi protein 73 activation of MMP-13promotes hepatocellular carcinoma cell invasion[J].Oncotarget, 2015, 6 (32) :33523-33533.

[21]LIU Y, ZHANG X, SUN T, et al.Knockdown of Golgi phosphoprotein 2 inhibits hepatocellular carcinoma cell proliferation and motility[J].Oncotarget, 2016, 7 (16) :21404-21415.

[22]CHEN X, WANG Y, TAO J, et al.m TORC1 up-regulates GP73to promote proliferation and migration of hepatocellular carcinoma cells and growth of xenograft tumors in mice[J].Gastroenterology, 2015, 149 (3) :741-752.

[23]JIANG K, LI W, ZHANG Q, et al.GP73 N-glycosylation at Asn144 reduces hepatocellular carcinoma cell motility and invasiveness[J].Oncotarget, 2016, 7 (17) :23530-23541.

[24]NORTON PA, COMUNALE MA, KRAKOVER J, et al.N-linked glycosylation of the liver cancer biomarker GP73[J].J Cell Biochem, 2008, 104 (1) :136-149.

[25]WRIGHT LM, YONG S, PICKEN MM, et al.Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2) [J].Int J Clin Exp Pathol, 2009, 2 (1) :34-47.

[26]WANG F, LI Z, LI L, et al.GP73 was upregulated in PBMC stimulated with Con A but failed to promote lymphocyte proliferation[J].Cell Biol Int, 2015, 39 (3) :334-340.

[27]BAO YX, CAO Q, YANG Y, et al.Expression and prognostic significance of golgiglycoprotein73 (GP73) with Epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC) [J].Diagn Pathol, 2013, 8 (1) :197.

[28]ZHOU YY, JIANG JC, YOU J, et al.Effect of Golgi phosphoprotein 2 (GOLPH2/GP73) on autophagy in human hepatocellular carcinoma Hep G2 cells[J].Tumour Bio, 2015, 36 (5) :3399-3406.

施引文献

资源附件(0)

访问统计